Que xie xìng nao cù zhong 6/5000 Ischemic stroke
Conditions
Interventions
experimental group:"Chinese Guidelines for the Diagnosis and Treatment of Acute Ischemic Stroke 2018" Acute Treatment of Cerebral Infarction+Jianpi Fuzheng method
control group:"Chinese Guidelines for the Diagnosis and Treatment of Acute Ischemic Stroke 2018" Acute Treatment of Cerebral Infarction+Jianpi Fuzheng placebo
Sponsors
Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Age
40 Years to 85 Years
Inclusion criteria
Inclusion criteria: (1) It also meets the diagnostic criteria of Western medicine for acute ischemic stroke and TCM apoplexy and the diagnostic criteria of TCM for spleen deficiency syndrome; (2) Diagnosed by head MRI; (3) Within 7 days of onset (= 40 years old; and = 7; (6) First onset or history of stroke but no severe disability (mRS score <= 1); (7) Join the trial voluntarily and sign the informed consent form.
Exclusion criteria
Exclusion criteria: (1) CT or MRI prompts: cerebral infarction combined with cerebral hemorrhage, subarachnoid hemorrhage, brain tumor; (2) Patients with intravenous thrombolysis or intravascular interventional therapy; (3) Patients with severe primary diseases such as heart, liver, kidney and hematopoietic system; (4) Patients with mental illness and those who cannot obtain reliable medical history data from their families; (5) Pregnant or lactating women.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Barthel Index;Stroke TCM Syndrome Score Scale; | — |
Secondary
| Measure | Time frame |
|---|---|
| Neurological assessment;Smart assessment;Fatigue;Emotion;Functional MRI; | — |
Countries
China
Contacts
Public ContactZhang Yunyun
Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine
Outcome results
None listed